Latest Insights in Appointments
Llusern announces changes to Exec team and new NED
21st April 2026 Llusern Scientific Announces Changes To Executive Management Team And New NED Appointments made to advance the commercial…
Llusern Scientific Announces Key Appointments to Strengthen its Executive Team
CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide…
Start a conversation with Llusern
Llusern is developing treatment-directing diagnostics for high-volume healthcare challenges, starting with rapid molecular UTI testing. To learn more about the company, the product and the opportunity ahead, speak to the Llusern team.
